Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst balloons during implantation procedures, which have resulted in significant difficulty...
-
-
The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
-
In one coordinated move, the U.S. Food and Drug Administration (FDA) opened transcatheter aortic valve replacement (TAVR) to low-risk patients with the simultaneous approvals of Edwards...
-
As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the technology used for transcatheter aortic valve replacement (TAVR) and the...
News | Stem Cell Therapies | August 22, 2019
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion...
Image courtesy of the American Heart Association
News | Cardiovascular Surgery | August 22, 2019
August 22, 2019 — The amount of opioids prescribed for patients after...
News | Heart Valve Technology | August 22, 2019
August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra...
Sponsored Content
Pass-through status and new CPT codes are expectred to boost usage of contrast-enhanced ultrasound procedures. The individuals who appear are for illustrative purposes only. All persons depicted are models and not real patients or healthcare professionals.
Case Study | Cardiovascular Ultrasound | May 29, 2019
As part of the ...
News | Stents | August 21, 2019
August 21, 2019 — Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the...
News | Angiography | August 21, 2019
August 21, 2019 — Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated...
Image courtesy of the American Heart Association
News | Hypertension | August 20, 2019
August 20, 2019 — In a...
Sponsored Content
Feature | Sudden Cardiac Arrest | October 25, 2018
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to...
Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.
News | Ventricular Assist Devices (VAD) | August 20, 2019
August 20, 2019 — Left...
Image courtesy of the American Heart Association
News | Cardiac Diagnostics | August 19, 2019
August 19, 2019 — People suffering from insomnia may have an...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo...
The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.
News | EP Mapping and Imaging Systems | August 19, 2019
August 19, 2019 — Scientists at Johns Hopkins have successfully created...
Image courtesy of UTHealth McGovern Medical School
News | Stroke | August 16, 2019
August 16, 2019 — Every second counts for ...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
Left, an illustration of the beginning of deployment for a CoreValve Evolut self-expanding transcatheter aortic replacement (TAVR) valve. Right, an illustration of the final balloon expansion of an Edwards Lifesciences Sapien 3 TAVR valve. Both valves received simultaneous FDA clearance for use in low-risk surgical patients. Clearing this last hurdle now allows wide-spread use of minimally invasive TAVR in all patients who otherwise would need an open-heart surgical valve replacement.
Feature | Heart Valve Technology | August 16, 2019 | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor
August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of ...
Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.
News | EP Lab | August 15, 2019
August 15, 2019 — Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart...
